2024-516008-41-00招募中1 期
Phase I study to evaluate safety and immunogenicity of V-212 in healthy adult volunteers.
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Virometix AG
- 入组人数
- 60
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Mark Sumeray
Scientific
Virometix AG
研究点 (1)
Loading locations...
相似试验
撤回
1 期
Phase I-Ib clinical trial of safety and immunobiology of prophylactic infusion of lymphocytes and NK cells after Allo-HCT.graft-versus-host disease2024-517002-28-00Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia S.L., Vall D Hebron Institute Of Oncology8
招募中
1 期
Phase 1 clinical trial to evaluate the safety, tolerability, and pharmacokinetics of intravenous single ascending doses of IM-250 in healthy volunteers.Herpes simplex virus encephalitis2025-523146-27-00Innovative Molecules GmbH30
招募中
2 期
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in InfantsNCT07286370GlaxoSmithKline537
招募中
1 期
A Phase 1 Study to Determine the Safety, and Pharmacokinetics of the Selective MET kinase Inhibitor, DO-2 in Patients With Advanced or Refractory Solid Tumours2023-504897-39-00Deuteroncology, Deuteroncology60
进行中（未招募）
1 期
A Phase I/IIa Study of the Safety, Immunogenicity and Parasite Growth Inhibitory Activity of AMA1-C1/Alhydrogel® + CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium falciparum Malaria - AMA1-C1/CPG Blood Stage ChallangeEUCTR2007-005389-11-GBniversity of Oxford10